Published in
Taylor and Francis Group, Expert Opinion on Drug Safety, p. 1-7, 2023
DOI: 10.1080/14740338.2023.2181340
Links
Tools
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases
Journal article published in 2023 by
Helen R. Gosselt 
,
Jette A. van Lint ,
Leanne J. Kosse ,
Phyllis I. Spuls,
Harald E. Vonkeman ,
Sander W. Tas,
Frank Hoentjen,
Michael T. Nurmohamed ,
Bart J. F. van den Bemt,
Martijn B. A. van Doorn ,
Naomi T. Jessurun
,
Jette A. van Lint ,
Leanne J. Kosse ,
Phyllis I. Spuls,
Harald E. Vonkeman ,
Sander W. Tas,
Frank Hoentjen,
Michael T. Nurmohamed ,
Bart J. F. van den Bemt,
Martijn B. A. van Doorn ,
Naomi T. Jessurun
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 